VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Antioxidant therapy
Phase 1
Small molecule
U
University of Chile
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Injury
1 trial
Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
Completed
·
U
University of Chile
·
Phase 1
·
NCT05215743
·
18 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Antioxidant therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Antioxidant therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Antioxidant therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Chile company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
U
University of Chile
Related News